002198.SZ
Guangdong Jiaying Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 3.26
−1.51%Oct 26, 2026, 07:54 UTC
ST Jiaying appointed Zhang Peng as deputy general manager and head of finance, with his term running from board approval until the end of the seventh board's term.
Source:Oct 26, 2026, 07:53 UTC
ST Jiaying reported revenue of 271 million yuan for the first three quarters of 2026, down 7.81% year over year, and attributable net profit of 1.7329 million yuan, down 92.05%.
Source:Oct 26, 2026, 07:53 UTC
ST Jiaying reported third-quarter 2026 revenue of 105 million yuan, up 10.87% year over year, and attributable net profit of 14.7117 million yuan, up 759.46%.
Source:Sep 4, 2026, 08:02 UTC
ST Jiaying's chief financial officer Zeng Yong resigned for personal reasons, effective upon delivery of the resignation report to the board; Zhang Peng will temporarily act as CFO until a new appointment.
Source: